Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Non Operating Income (2016 - 2023)

Historic Non Operating Income for Pharma-Bio Serv (PBSV) over the last 13 years, with Q3 2023 value amounting to $126985.0.

  • Pharma-Bio Serv's Non Operating Income rose 33654.6% to $126985.0 in Q3 2023 from the same period last year, while for Jul 2023 it was $628228.0, marking a year-over-year increase of 142666.3%. This contributed to the annual value of $13418.0 for FY2022, which is 9932.15% down from last year.
  • Latest data reveals that Pharma-Bio Serv reported Non Operating Income of $126985.0 as of Q3 2023, which was up 33654.6% from $192616.0 recorded in Q2 2023.
  • Over the past 5 years, Pharma-Bio Serv's Non Operating Income peaked at $2.0 million during Q3 2021, and registered a low of -$53683.0 during Q3 2022.
  • Over the past 5 years, Pharma-Bio Serv's median Non Operating Income value was $48584.0 (recorded in 2020), while the average stood at $167833.2.
  • As far as peak fluctuations go, Pharma-Bio Serv's Non Operating Income tumbled by 13689.7% in 2020, and later surged by 3998861.79% in 2023.
  • Over the past 5 years, Pharma-Bio Serv's Non Operating Income (Quarter) stood at $57436.0 in 2019, then fell by 28.31% to $41178.0 in 2020, then plummeted by 96.82% to $1310.0 in 2021, then soared by 4639.08% to $62082.0 in 2022, then surged by 104.54% to $126985.0 in 2023.
  • Its last three reported values are $126985.0 in Q3 2023, $192616.0 for Q2 2023, and $246545.0 during Q1 2023.